SAM
ACAD icon

Shell Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$130K Sell
6,015
-244
-4% -$5.27K ﹤0.01% 921
2025
Q1
$104K Sell
6,259
-271
-4% -$4.5K ﹤0.01% 1010
2024
Q4
$120K Hold
6,530
0.01% 1002
2024
Q3
$100K Buy
+6,530
New +$100K ﹤0.01% 1051
2024
Q1
$112K Buy
6,904
+2,474
+56% +$40.1K 0.01% 983
2023
Q4
$139K Sell
4,430
-1,351
-23% -$42.4K 0.01% 973
2023
Q3
$120K Sell
5,781
-88
-1% -$1.83K 0.01% 1043
2023
Q2
$141K Sell
5,869
-32
-0.5% -$769 0.01% 1032
2023
Q1
$111K Sell
5,901
-20
-0.3% -$376 ﹤0.01% 1075
2022
Q4
$94K Sell
5,921
-1,152
-16% -$18.3K ﹤0.01% 1164
2022
Q3
$116K Sell
7,073
-1,886
-21% -$30.9K ﹤0.01% 1178
2022
Q2
$126K Buy
8,959
+4,633
+107% +$65.2K ﹤0.01% 1227
2022
Q1
$105K Sell
4,326
-653
-13% -$15.9K ﹤0.01% 1290
2021
Q4
$116K Sell
4,979
-82
-2% -$1.91K ﹤0.01% 1313
2021
Q3
$84K Sell
5,061
-200
-4% -$3.32K ﹤0.01% 1317
2021
Q2
$128K Hold
5,261
﹤0.01% 1322
2021
Q1
$136K Sell
5,261
-5,322
-50% -$138K ﹤0.01% 1230
2020
Q4
$566K Sell
10,583
-2,591
-20% -$139K 0.01% 744
2020
Q3
$543K Hold
13,174
0.01% 645
2020
Q2
$639K Sell
13,174
-148
-1% -$7.18K 0.02% 560
2020
Q1
$563K Sell
13,322
-203
-2% -$8.58K 0.02% 616
2019
Q4
$579K Sell
13,525
-296
-2% -$12.7K 0.01% 816
2019
Q3
$497K Sell
13,821
-119
-0.9% -$4.28K 0.01% 891
2019
Q2
$373K Sell
13,940
-319
-2% -$8.54K 0.01% 1017
2019
Q1
$383K Hold
14,259
0.01% 1001
2018
Q4
$231K Sell
14,259
-1,200
-8% -$19.4K 0.01% 1021
2018
Q3
$321K Hold
15,459
0.01% 1055
2018
Q2
$236K Sell
15,459
-873
-5% -$13.3K ﹤0.01% 1047
2018
Q1
$367K Hold
16,332
0.01% 977
2017
Q4
$492K Buy
+16,332
New +$492K 0.01% 910
2017
Q3
Sell
-11,622
Closed -$324K 1090
2017
Q2
$324K Hold
11,622
0.01% 994
2017
Q1
$400K Sell
11,622
-4,988
-30% -$172K 0.01% 957
2016
Q4
$479K Sell
16,610
-17,034
-51% -$491K 0.01% 891
2016
Q3
$1.07M Buy
+33,644
New +$1.07M 0.02% 633